TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Mean proportion of Tregs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Maintenance of induced C-peptide production
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Pain and comfort improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical activity level improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional improvement score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Good-to-excellent outcomes according to the DRUJ evaluation system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: alanine transaminase reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: total number of disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lifetime risk estimate (LRE) accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feelings of risk
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of participants meeting safe sleep criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Balance markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DGI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Turbinate size reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: current suicidal ideation
Endpoint domain: Adverse events/effects
Primary endpoint: suicide attempt in the past 6 months
Endpoint domain: Adverse events/effects
Primary endpoint: 2D:4D ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean number of decayed, missing or filled permanent teeth (DMFT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Salivary pH level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of episodes with treatment records positive for NG or CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Odds of CKD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: jaw pain improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: jaw dysfunction improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in hepatitis B surface antigen (HBsAg) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median time to desaturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: median lowest SpO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: total resorption rate (RR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: skeletal transverse dimensions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: inter-molar width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: restoration color
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: luster
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pulp survival
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to discharge alive from the hospital
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of BD
Endpoint domain: Mortality/survival
Primary endpoint: chronic eGFR slopes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: changes in glycated hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: changes in hematocrit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: peripheral arterial disease-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: hospital cost savings
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Resultant ground reaction force (GRF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Deterrent effect of DUI enforcement intensity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Effectiveness of license suspension
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Impact of jail penalties on driving decisions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Lower health literacy identification
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Average cost per enrolled participant
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean time to full enrollment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: gain in KG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: shrinkage amount of KG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: shrinkage ratio of KG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported coping skills
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: mental health stigma
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: CTV coverage (D95%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CTV homogeneity (D5% - D95%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Target coverage robustness (CTV D95% bandwidth)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage improvement in worst average daily pruritus NRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvements in eczema-related sleep NRS
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Meaningful changes in Dermatology Life Quality Index
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: reduced new use of insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: reduced need for greater than 20% insulin dose increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: increased proportion achieving sustained greater than 20% insulin dose reductions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: acceptability of gPM+ intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: feasibility of gPM+ intervention
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: safety of gPM+ intervention
Endpoint domain: Adverse events/effects
Primary endpoint: Provision of nutritious foods
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection rate of cervical cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Detection rate of cervical intraepithelial neoplasia (CIN)2+
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: IMS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak power (in watts)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of patients with any atelectasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: proportion of patients with bilateral atelectasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: number of atelectatic bronchial segments
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Quality of life (AFEQT summary score)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: overall portrayal scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total active range of motion (ROM) of the digits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circulating BMP4 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ICIQ-LUTSqol score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Importance attributed to avoiding surgery
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Non-union rates
Endpoint domain: Adverse events/effects
Primary endpoint: peak exercise capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Axial Length (AXL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: 4-year incidence of vision-threatening retinopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ophthalmological outcomes
Primary endpoint: Drive for thinness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: interleukin 6 plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: problems finding a well‐fitting bra
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Low-density lipoprotein cholesterol reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: High-density lipoprotein cholesterol reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: AKSS Knee Score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EQ-5D-5L Index improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: spasticity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: motor function scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: BL-V measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sensitivity of diagnostic methods
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of hospitalization for AMI
Endpoint domain: Adverse events/effects
Primary endpoint: Time to RRT independence
Endpoint domain: Mortality/survival
Primary endpoint: early antiplatelet evidence for minor stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: PBFSFS 3 or 4 achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to pharmacotherapy course
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Improvements in TSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incident frailty
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost as a barrier to SuAVR use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Lower limb spasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neuromuscular and connective tissue outcomes
Primary endpoint: Reduction in stomatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stress level reduction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Complete sensory blockade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete motor blockade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perceived color difference (ΔE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OBL score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ACR20/50 response rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ∆CRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total neurodevelopmental scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PMO
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MAMO
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: in-hospital major complications or death
Endpoint domain: Mortality/survival
Primary endpoint: MMD gain post-restoration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain mean score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of PI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of GI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PSD of EMG values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: level of compliance with midwifery professional codes of ethics
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: applicability rate of midwifery professional codes of ethics
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: risk of non-atypical BPED
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of patients alive and disease-free at 6 months
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of patients alive and free from recurrence outside the urothelial tract at 6 months
Endpoint domain: Mortality/survival
Primary endpoint: Access to pharmacogenomic results
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Prescribing of genomically high-risk medications
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical outcomes related to prescribing decisions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in ICSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Schirmer tear test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-efficacy of pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 6-month total costs per subject
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: number of clinic visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: CV death or hHF prevention
Endpoint domain: Mortality/survival
Primary endpoint: Rocuronium consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom cluster incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients with PTS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First attempt success rate of radial artery cannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Procedure time to success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Overall number of cannulation attempts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Combined risk of death, hospitalization for heart failure or urgent heart failure visit
Endpoint domain: Mortality/survival
Primary endpoint: Risk of inpatient or outpatient worsening heart failure events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Parental depression, anxiety, stress, and self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Infant healthcare utilization (ED visits, hospitalizations, immunization status)
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Positive soft tissue margin rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Investigational cigarette purchasing behavior
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: 10 year all-cause death
Endpoint domain: Mortality/survival
Primary endpoint: Delaying gastric emptying
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reduction in RMBPC
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Differences in CES-D
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Differences in Short ZBI
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Average pain in activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain-related sleep disturbance
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Episodes of postoperative oral bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: BRS change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Freedom from persistent type Ia endoleak
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chimney grafts patency rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-day procedure related mortality rates
Endpoint domain: Mortality/survival
Primary endpoint: plasma glucose iAUC 0-30 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean reduction in pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MCRI (Microbial Catheter-Related Infection)
Endpoint domain: Adverse events/effects
Primary endpoint: Catheter insertion site colonization
Endpoint domain: Adverse events/effects
Primary endpoint: Clinically meaningful changes in routine laboratory parameters
Endpoint domain: Adverse events/effects
Primary endpoint: POCO (Patient-Oriented Composite Outcome)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DOCO (Device-Oriented Composite Outcome)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absenteeism reduction
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Reduction in unhealthy days experienced
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: freedom from definitive deterioration of sexual function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: muscle activity in EMG0–200
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximal neural drive
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: spasticity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Enhancement of person-centred care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Individualised parental education
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Noninferiority of novel SCB to everolimus-eluting stent
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Fatigue levels postintervention
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: CD8a levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Normalization of fecal calprotectin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Restoration of normal composition of intestinal microbiota
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Remission of disease
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total dose of KCl administered
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to reach asystole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total duration of the procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in peak Vo2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean blood flow velocity of vertebral artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of rescue analgesics requested
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in attitude scale score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in knowledge scale score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Development of Retinopathy of Prematurity (ROP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OSDI light sensitivity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ocular pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hexagonality of endothelial cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive impairment rate by MMSE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: HADS-depression score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: SAS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: tolerance to the procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: effectiveness in the immediate, short, and medium terms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of first return plasma donation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Berg balance score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes